Target intelligence / Profile preview

Mitochondrial inner membrane (MIM) (MIM)

Target
MIM
Molecular classification
Organelle membrane, Lipid bilayer, Phospholipid environment
01

Overview

The mitochondrial inner membrane (MIM) is a highly protein-dense lipid bilayer that serves as the primary site for cellular energy production through oxidative phosphorylation. It is uniquely characterized by the presence of cardiolipin, a dimeric phospholipid that is essential for the assembly and stability of respiratory chain supercomplexes and the maintenance of cristae morphology (PMID: 30639642). The mitochondrial lipid environment specifically refers to this cardiolipin-rich milieu, which is highly susceptible to oxidative damage due to its proximity to the electron transport chain. In diseases such as heart failure, Barth syndrome, and ischemia-reperfusion injury, cardiolipin peroxidation leads to the collapse of cristae and the release of pro-apoptotic factors like cytochrome c (PMID: 24631325). Drugs like elamipretide (SS-31) target this environment by binding to cardiolipin, thereby preventing its oxidation and preserving mitochondrial bioenergetics (PMID: 23861545). Consequently, the MIM is an emerging therapeutic target for conditions characterized by mitochondrial decay and metabolic dysfunction.

Other names
Inner mitochondrial membraneIMMMitochondrial lipid bilayerCardiolipin-rich membrane environment
02

Mechanism of action

Cardiolipin stabilization and protection against lipid peroxidation to maintain cristae structure and electron transport chain efficiency.

03

Biological functions

Oxidative phosphorylationATP synthesisApoptosis regulationMitochondrial fusion and fissionMetabolite transport
04

Disease associations

Mitochondrial myopathyBarth syndromeHeart failureIschemia-reperfusion injuryNeurodegenerative disease
05

Safety considerations

Potential disruption of systemic lipid metabolismInterference with normal apoptotic pathwaysOff-target effects on non-mitochondrial membranes
06

Interacting drugs

Elamipretide (SS-31)

3 more in the full profile.

07

Biomarkers

Cardiolipin contentMitochondrial membrane potentialOxygen consumption rate (OCR)Plasma lactate levels

Beyond the preview

Go deeper on Mitochondrial inner membrane (MIM) (MIM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial inner membrane (MIM) (MIM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call